Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT02457338Not ApplicableActive Not Recruiting

Infant Microbiota and Probiotic Intake Study

Role: collaborator

NCT03222804Not ApplicableWithdrawn

Milk Oriented Microbiota

Role: collaborator

NCT05129384Not ApplicableTerminated

The COLIC Study: Colonization of the Infant Gut With B. Infantis EVC001 to Reduce Symptoms of Colic

Role: lead

NCT03939546Not ApplicableCompleted

The FOUNDATION Study

Role: lead

NCT03994315Not ApplicableCompleted

The EFFECT Study: Probiotic and HMO Supplementation in Infants

Role: lead

NCT03601936Not ApplicableTerminated

User Testing of the Evivo Screening Test

Role: lead

NCT03476447Not ApplicableCompleted

Rescuing the Microbiome Effectively With Different Doses of B. Infantis in Infants

Role: lead

All 7 trials loaded